Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

High doses of finasteride cause cell growth and tumors in mice.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Castration and finasteride lower urinary oxalate in male rats, potentially treating urolithiasis.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Most female students at Qassim University know about PCOS, but there are still misunderstandings about it.